IL6 and Stroke: After multivariate adjustment (age, gender, statin therapy, years of school, smoking, BMI, creatinine, uric acid, IL-6 plasma levels, serum albumin, hypertension, diabetes, CHD, stroke, weight loss >4.5 kg in the last year, and diagnosis of cancer), group 4 displayed a significant increase in the risk of death (H.R.:1.58; 95%CI:1.11–2.25) compared with group 1.